Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Accounts Payables: 2013-2015

Historic Accounts Payables for Tvardi Therapeutics (TVRD) over the last 2 years, with Dec 2015 value amounting to $5.3 million.

  • Tvardi Therapeutics' Accounts Payables rose 170.71% to $5.3 million in Q4 2015 from the same period last year, while for Dec 2015 it was $5.3 million, marking a year-over-year increase of 170.71%. This contributed to the annual value of $5.3 million for FY2015, which is 170.71% up from last year.
  • As of Q4 2015, Tvardi Therapeutics' Accounts Payables stood at $5.3 million, which was up 56.14% from $3.4 million recorded in Q3 2015.
  • Tvardi Therapeutics' Accounts Payables' 5-year high stood at $5.3 million during Q4 2015, with a 5-year trough of $1.9 million in Q4 2014.
  • For the 3-year period, Tvardi Therapeutics' Accounts Payables averaged around $3.0 million, with its median value being $2.5 million (2014).
  • Data for Tvardi Therapeutics' Accounts Payables shows a peak YoY increase of 170.71% (in 2015) and a maximum YoY decrease of 18.68% (in 2015) over the last 5 years.
  • Tvardi Therapeutics' Accounts Payables (Quarterly) stood at $2.0 million in 2013, then declined by 0.61% to $1.9 million in 2014, then soared by 170.71% to $5.3 million in 2015.
  • Its Accounts Payables was $5.3 million in Q4 2015, compared to $3.4 million in Q3 2015 and $3.1 million in Q2 2015.